3

SEC Filing Details

Document Details

Form
Filing Date
Jun 26, 2018
Document Date
Jun 25, 2018
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
DOVA Pharmaceuticals, Inc.
Issuer
Dova Pharmaceuticals, Inc.
Filer
Wysenski Nancy